eTMF Best Practice for a Lean Team
The TMF is the official record of the clinical study for Regulatory Authorities, be it the FDA, Health Canada, or…
Recovering a Derailed Clinical Trial – Best Practices
Partnerships sometimes do not work out as intended. For medium size and smaller biotech companies enlisting the services of a…
Doubly Nimble: why you should open global P1 clinical trials in Canada on Day 1
With agility increasingly becoming the most important global driver of success, it’s worth noting that Canadian oncology research center Phase…
Diversity in Clinical Trial Participants: Canada Holds Promise
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…
Some Facts About Canada… Mitigate COVID-19 Impact on Your Clinical Trials
People often adhere to a myth and perpetuate it in answer to a difficult question, ending all further inquiry into…
Going Above-and-Beyond – What Can Your Specialized Oncology CRO Do for You?
Clinical research is a growing and fascinating field marked by increasing complexity and competitive surroundings. CROs can help their Sponsors…
Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
What is Most Important When Conducting Oncology Clinical Research in Canada?
Developing oncology compounds is a constantly evolving process, and with the dramatic rise in costs, and competitive trials, making every…
Your Specialized Oncology CRO as Strategic Advisor – Real World Evidence
Optimizing the partnership between Sponsors and CROs can move the relationship from a tactical client/vendor operating model to a more…
What to Look for When Selecting a CRO – Real World Evidence
There is a myriad of factors involved in selecting a CRO. Do CRO team members have the necessary therapeutic expertise?…